Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 26;15(7):e245890.
doi: 10.1136/bcr-2021-245890.

Insulinoma mimic: methadone-induced hypoglycaemia

Affiliations
Case Reports

Insulinoma mimic: methadone-induced hypoglycaemia

Sarah Kanbour et al. BMJ Case Rep. .

Abstract

Methadone use for opioid use disorder and chronic pain has increased since the start of the century with about 4.4 million dispensed prescriptions in 2009. With increased use of methadone, there has been increasing reporting of less commonly reported side effects (ie, hypoglycaemia). Here, we describe a woman in her 70s with history of opioid use disorder on methadone, stage 4 chronic kidney disease and prior hypoglycaemic episodes who initially presented with perforated gastric ulcer requiring surgical repair. Her perioperative course was complicated by profound hyperinsulinaemic hypoglycaemia. Given concern for methadone-induced hypoglycaemia, methadone was discontinued with monitoring of subsequent blood glucose, insulin, C peptide, proinsulin, β-hydroxybutyrate and blood methadone levels. As the serum methadone levels decreased, insulin levels substantially decreased in parallel. After 21 days off methadone, dextrose infusion was discontinued with restoration of euglycaemia. In a patient with hyperinsulinaemic hypoglycaemia and methadone use, it is important to consider discontinuing methadone and re-evaluate fasting glucose levels prior to an extensive and invasive insulinoma workup.

Keywords: Drugs: endocrine system; Endocrine system; Psychiatry (drugs and medicines).

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Glucose and methadone levels during three monitored fasts. The first trial is labelled day 0, the second trial occurred 1 day later (day +1) and the third trial took place 10 days later (day +10). Dextrose administration is indicated by the x and the blood glucose level following dextrose is included. Illustrated by Aanika Balaji.
Figure 2
Figure 2
Insulinoma laboratory investigation among three monitored fasts. The first trial is labelled day 0, the second trial occurred 1 day later (day +1) and the third trial took place 10 days later (day +10). The laboratory values for insulin, C peptide, proinsulin, β-hydroxybutyrate and serum methadone levels are included for all three trials. Illustrated by Aanika Balaji.

References

    1. Paulozzi L J, Mack KA, Jones CM. Vital signs: risk for overdose from methadone used for pain Relief-United states, 1999-2010. Division of Unintentional Injury Prevention 2012. - PubMed
    1. Alderks CE. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-2015 (update. Rockville (MD: Substance Abuse and Mental Health Services Administration, 2017. - PubMed
    1. Makunts T, U A, Atayee RS, et al. . Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. Sci Rep 2019;9:12490. 10.1038/s41598-019-48955-y - DOI - PMC - PubMed
    1. Brown R, Kraus C, Fleming M, et al. . Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J 2004;80:654–9. 10.1136/pgmj.2004.022988 - DOI - PMC - PubMed
    1. Green IC, Perrin D, Pedley KC, et al. . Effect of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia 1980;19:158–61. 10.1007/BF00421864 - DOI - PubMed

Publication types